Kevin is currently director of Sterile Injectables and Biotech Technology and a member of the Pfizer Global Supply Global Technology & Engineering team.  In this role, Kevin and his team are responsible for providing technical leadership and support for all new and marketed vaccine/biological products.  This scope includes 2nd generation process development, technology transfer, supply robustness, new technology development.

Kevin joined Pfizer in 2011 as a member of the Manufacturing Sciences and Technology team at the Grange Castle, Ireland, site.  He has held various technical and leadership roles in large molecule process and technology development, scale-up, and clinical and commercial manufacturing.  Prior to joining Pfizer in 2011, he was a work fo Merck and CO as small  molecule process development scientist.

Kevin received a PhD and BSC  from Maynooth University Ireland. Followed by postdoctoral stays at the  University of Basel Switzerland  and Université de Strasbourg France as a supra molecular organic chemist

Kevin lives in Dublin with his wife and two children.

Talks

• Case Study: Supplying mRNA COVID 19 Vaccine at Unprecedented Pace & Scale